Ethan Mollick on the four rules of Co-Intelligence with AI Penn In the News Forbes Ethan Mollick on the four rules of Co-Intelligence with AI In a Q&A, Ethan Mollick of the Wharton School discusses his transition from entrepreneurship to academia, the most important concepts that need to be taught to entrepreneurs, and the four rules of Co-Intelligence with AI. Embracing AI in our lives Penn In the News RNZ/Radio New Zealand Embracing AI in our lives In his new book, “Co-intelligence: Living and Working with AI,” Ethan Mollick of the Wharton School says that people should learn to work with AI as a tool to be more creative, more capable, and even more human. Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Penn In the News Los Angeles Times Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Ethan Mollick of the Wharton School says that social media apps are investing in AI to become “stickier” for consumers, keeping users on their platforms for as long as possible. Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Penn In the News The Wall Street Journal Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Ethan Mollick of the Wharton School is profiled for his knowledge and expertise in generative artificial intelligence. Boycotts aren’t the only way to hold companies accountable Penn In the News BBC Boycotts aren’t the only way to hold companies accountable Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations. Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Embracing AI in our lives Penn In the News RNZ/Radio New Zealand Embracing AI in our lives In his new book, “Co-intelligence: Living and Working with AI,” Ethan Mollick of the Wharton School says that people should learn to work with AI as a tool to be more creative, more capable, and even more human. Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Penn In the News Los Angeles Times Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Ethan Mollick of the Wharton School says that social media apps are investing in AI to become “stickier” for consumers, keeping users on their platforms for as long as possible. Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Penn In the News The Wall Street Journal Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Ethan Mollick of the Wharton School is profiled for his knowledge and expertise in generative artificial intelligence. Boycotts aren’t the only way to hold companies accountable Penn In the News BBC Boycotts aren’t the only way to hold companies accountable Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations. Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Penn In the News Los Angeles Times Meta now has an AI chatbot. Experts say get ready for more AI-powered social media Ethan Mollick of the Wharton School says that social media apps are investing in AI to become “stickier” for consumers, keeping users on their platforms for as long as possible. Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Penn In the News The Wall Street Journal Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Ethan Mollick of the Wharton School is profiled for his knowledge and expertise in generative artificial intelligence. Boycotts aren’t the only way to hold companies accountable Penn In the News BBC Boycotts aren’t the only way to hold companies accountable Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations. Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Penn In the News The Wall Street Journal Meet the AI expert advising the White House, JPMorgan, Google and the rest of corporate America Ethan Mollick of the Wharton School is profiled for his knowledge and expertise in generative artificial intelligence. Boycotts aren’t the only way to hold companies accountable Penn In the News BBC Boycotts aren’t the only way to hold companies accountable Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations. Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Boycotts aren’t the only way to hold companies accountable Penn In the News BBC Boycotts aren’t the only way to hold companies accountable Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations. Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Penn In the News WHYY (Philadelphia) Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships. How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
How to die in good health Penn In the News The New Yorker How to die in good health PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one. Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Bridging Blocks has Philadelphians focused on dispelling myths around immigration Penn In the News WHYY (Philadelphia) Bridging Blocks has Philadelphians focused on dispelling myths around immigration Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous. AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
AI will change work, for better and worse Penn In the News Yahoo! Finance AI will change work, for better and worse Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat. Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval. Load More
Many cancer drugs remain unproven five years after accelerated approval, a study finds Penn In the News Associated Press Many cancer drugs remain unproven five years after accelerated approval, a study finds PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval.